Quad Helix vs RME for Posterior Cross-bite in Egyptian Children (Expansion)

March 24, 2026 updated by: Moustafa Galal Borham Moustafa Saad, Al-Azhar University

Quad Helix Versus Rapid Maxillary Expanders in the Treatment of Posterior Cross-bite During Mixed Dentition in a Sample of Egyptian Children: A Randomized Clinical Study.

This randomized clinical trial aims to evaluate and compare the effectiveness of the Quad Helix (QH) appliance versus Rapid Maxillary Expanders (RME) in treating posterior cross-bite in Egyptian children during the mixed dentition stage. The study will also assess patient comfort and pain levels associated with each appliance.

Study Overview

Detailed Description

The study involves 20 orthodontic patients aged 9-12 years with posterior cross-bite. Group A will receive the Quad Helix appliance, while Group B will receive Rapid Maxillary Expanders. Evaluation will be based on orthodontic study models, clinical photographs, and various radiographs including CBCT. Treatment will continue until complete correction is achieved, followed by a 3-month passive retention period.

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt, 00000
        • Faculty of Dental medicine (boys) ,Cairo,Al-Azhar University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Children aged 9-12 years in the mixed dentition stage
  2. Presence of posterior cross-bite due to transverse maxillary deficiency
  3. No previous history of orthodontic treatment
  4. Good oral hygiene and cooperative behavior
  5. No significant antero-posterior or vertical skeletal discrepancies

Exclusion Criteria:

  1. Patient with craniofacial anomalies
  2. Presence of systemic diseases or syndromes affecting bone metabolism
  3. Extensive dental caries or untreated periodontal disease
  4. History of trauma or surgery affecting the maxilla or mandible

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group A:Quad Helix Appliance
Participants in this group will receive treatment using a fixed Quad Helix (QH) appliance to correct posterior cross-bite. The appliance is fabricated using stainless steel wire and soldered to bands on the upper first permanent molars.
It is a fixed orthodontic appliance fabricated using stainless-steel wire and soldered to bands on upper first permanent molars.
Active Comparator: Group B: Rapid maxillary expanders
Participants in this group will receive treatment using fixed Rapid Maxillary Expanders (RME) bonded on the upper first permanent molars and pre-molars
It is a fixed expansion device bonded on the upper first permanent molars and pre-molars. Activation is done at a rate of 0.25 mm twice daily (two turns per day)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maxillary Arch Width Changes
Time Frame: Baseline and 6 months
Measured on dental castes at the level of inter molar / inter canine width and Cone-beam computed tomography (CBCT) for upper arch
Baseline and 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Treatment duration
Time Frame: At the time of complete cross-bite correction (average of 6 months)
At the time of complete cross-bite correction (average of 6 months)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Al Dany Atwa Mohamed, Professor, Faculty of dental medicine(boys) Cairo ,Al Azhar University
  • Study Director: Mahmoud Mohamed Fathy Abo ELMahasen, Associated Professor, Faculty of dental medicine(boys) Cairo ,Al Azhar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 30, 2026

Primary Completion (Estimated)

December 30, 2027

Study Completion (Estimated)

March 31, 2028

Study Registration Dates

First Submitted

March 20, 2026

First Submitted That Met QC Criteria

March 24, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 24, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

IPD will not be shared to maintain participant confidentiality and because the data is proprietary to the Orthodontic Department at Al-Azhar University.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Transverse Maxillary Deficiency

Clinical Trials on Quad Helix(QH) Appliance

Subscribe